Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Invested Capital (2016 - 2025)

Tandem Diabetes Care's Invested Capital history spans 13 years, with the latest figure at $155.2 million for Q4 2025.

  • For Q4 2025, Invested Capital fell 48.92% year-over-year to $155.2 million; the TTM value through Dec 2025 reached $155.2 million, down 48.92%, while the annual FY2025 figure was $155.2 million, 48.92% down from the prior year.
  • Invested Capital reached $155.2 million in Q4 2025 per TNDM's latest filing, up from $133.0 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $449.6 million in Q2 2022 to a low of $133.0 million in Q3 2025.
  • Average Invested Capital over 5 years is $312.2 million, with a median of $313.8 million recorded in 2023.
  • Peak YoY movement for Invested Capital: surged 51.28% in 2021, then tumbled 52.22% in 2025.
  • A 5-year view of Invested Capital shows it stood at $433.1 million in 2021, then rose by 1.58% to $439.9 million in 2022, then decreased by 28.71% to $313.6 million in 2023, then fell by 3.15% to $303.8 million in 2024, then crashed by 48.92% to $155.2 million in 2025.
  • Per Business Quant, the three most recent readings for TNDM's Invested Capital are $155.2 million (Q4 2025), $133.0 million (Q3 2025), and $133.3 million (Q2 2025).